Balyasny Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-115,624	Closed	-$306K	–	3216
2025 Q3	$306K	Buy	+115,624	New	+$224K	﹤0.01%	2570
2024 Q2	–	Sell	-159,038	Closed	-$426K	–	2709
2024 Q1	$426K	Buy	159,038 +121,850	+328%	+$296K	﹤0.01%	2113
2023 Q4	$111K	Buy	+37,188	New	+$48.2K	﹤0.01%	2374
2023 Q3	–	Sell	-16,039	Closed	-$22.3K	–	2381
2023 Q2	$22.3K	Sell	16,039 -4,755,321	-100%	-$6.64M	﹤0.01%	2155
2023 Q1	$7.59M	Buy	4,771,360 +1,342,223	+39%	+$6.93M	0.02%	893
2022 Q4	$21.4M	Buy	3,429,137 +2,633,466	+331%	+$18.8M	0.06%	466
2022 Q3	$5.33M	Buy	795,671 +783,700	+6,547%	+$5.38M	0.02%	957
2022 Q2	$76K	Buy	+11,971	New	+$67.9K	﹤0.01%	2312
2020 Q3	–	Sell	-62,282	Closed	-$2.47M	–	1380
2020 Q2	$3.2M	Sell	62,282 -199,456	-76%	-$8.35M	0.03%	621
2020 Q1	$8.25M	Buy	261,738 +11,361	+5%	+$600K	0.1%	286
2019 Q4	$14.9M	Buy	250,377 +115,147	+85%	+$5.18M	0.09%	323
2019 Q3	$4.96M	Sell	135,230 -26,218	-16%	-$1.04M	0.03%	550
2019 Q2	$7.51M	Buy	+161,448	New	+$7.58M	0.05%	487
2018 Q4	–	Sell	-9,894	Closed	-$477K	–	1487
2018 Q3	$439K	Sell	9,894 -31,330	-76%	-$1.44M	﹤0.01%	1416
2018 Q2	$1.62M	Sell	41,224 -109,217	-73%	-$5.52M	0.01%	1005
2018 Q1	$10.9M	Sell	150,441 -252,723	-63%	-$18.6M	0.05%	500
2017 Q4	$26.5M	Buy	403,164 +10,014	+3%	+$539K	0.08%	323
2017 Q3	$19.7M	Buy	393,150 +192,667	+96%	+$9.29M	0.08%	330
2017 Q2	$9.28M	Buy	200,483 +150,983	+305%	+$5.55M	0.04%	562
2017 Q1	$1.75M	Buy	+49,500	New	+$1.13M	0.01%	945